+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adult Hemoglobinopathy Testing Market - Global Forecast 2026-2032- Product Image
Adult Hemoglobinopathy Testing Market - Global Forecast 2026-2032- Product Image
Sale

Adult Hemoglobinopathy Testing Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887529
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Adult Hemoglobinopathy Testing Market is projected to reach USD 2.75 Billion in 2026. It is expected to continue growing at a CAGR of 6.00%, reaching USD 3.92 Billion by 2032.

Adult hemoglobinopathy testing supports the diagnosis, classification, and clinical management of inherited disorders affecting hemoglobin. Testing commonly combines hematology analysis with hemoglobin separation, molecular methods, and confirmatory interpretation. Demand is shaped by diagnostic access, clinical awareness, migration patterns, family screening, prenatal and preconception services, and the need to distinguish inherited disease from acquired or clinically similar conditions.

Diagnostic Pathways Are Becoming More Integrated and Precise

The testing landscape is shifting from isolated assays toward coordinated diagnostic pathways that link complete blood counts, hemoglobin analysis, genetic confirmation, and clinical review. Laboratories are placing greater emphasis on standardized interpretation, quality assurance, specimen suitability, and referral pathways for complex cases. Expanded screening of relatives and at-risk adults is also increasing the importance of efficient workflows that can manage both routine confirmation and uncommon variants.

Artificial Intelligence Strengthens Interpretation, Triage, and Laboratory Operations

Artificial intelligence can support adult hemoglobinopathy testing by identifying atypical result patterns, prioritizing samples for review, assisting variant classification, and detecting inconsistencies between hematology and hemoglobin-analysis data. Its strongest near-term value is likely to come from decision support rather than autonomous diagnosis. Effective adoption requires representative training data, transparent validation, human oversight, cybersecurity controls, and integration with laboratory information systems. AI should complement specialist interpretation, particularly where transfusion history, mixed phenotypes, or rare variants complicate results.

Regional Insights: Access and Standardization Vary Across Six Major Regions

North America is characterized by relatively mature laboratory infrastructure and increasing integration of molecular confirmation with clinical services. Europe benefits from established specialist networks, while differences in national pathways and population composition continue to influence access. The Middle East has a strong rationale for premarital, family, and targeted adult testing, with implementation shaped by public-health programs and laboratory capacity. Africa faces substantial unmet need linked to uneven access, workforce constraints, and the burden of undiagnosed disease. Asia-Pacific combines advanced testing ecosystems in some economies with major access gaps across others. Latin America is progressing through referral networks and improved diagnostic awareness, although geographic coverage, reimbursement, and laboratory standardization remain important considerations.

Group Insights: Economic and Policy Blocs Shape Testing Capacity

ASEAN countries show varied laboratory maturity and benefit from regional cooperation, workforce development, and referral connectivity. BRICS members encompass diverse disease patterns, health-system structures, and diagnostic capabilities, making harmonized protocols and affordable access particularly relevant. The European Union supports cross-border scientific and clinical collaboration, while national implementation still differs. G7 systems generally have strong specialist capacity and data infrastructure, but must address equitable access and population diversity. GCC countries have strong incentives to connect adult testing with family health, premarital services, and genomic medicine. NATO members span different health systems, creating opportunities for shared preparedness, laboratory standards, and specialist education without assuming uniform access.

Country Insights: National Priorities Reflect Distinct Disease and Health-System Contexts

Australia combines advanced pathology services with the need to serve remote communities and culturally diverse populations. Brazil and Mexico continue to benefit from stronger referral pathways and broader access outside major urban centers. Canada and the United States have substantial specialist capability, while geographic inequity and complex coverage arrangements remain practical concerns. China and India require scalable approaches that connect high-volume hematology services with confirmatory testing. Japan and South Korea emphasize quality, precision, and integration with advanced clinical infrastructure. France, Germany, Italy, Spain, and the United Kingdom have established expertise, with ongoing attention to harmonized pathways, specialist workforce capacity, and equitable regional access. Russia’s testing environment reflects the importance of maintaining broad laboratory coverage, reliable supply chains, and consistent clinical interpretation across geographically dispersed services.

Priorities for Leaders: Build Connected, Equitable, and Clinically Governed Testing

Industry leaders should develop tiered testing pathways that match assay complexity to clinical need, while ensuring clear escalation to molecular or specialist review. Investments should prioritize interoperability, external quality assessment, staff training, and referral networks that extend beyond major hospitals. Organizations should evaluate AI through prospective validation, bias monitoring, explainability testing, and defined accountability for final interpretation. Partnerships with public-health agencies, hematology specialists, primary-care providers, and patient communities can improve appropriate testing and follow-up. Access strategies should address affordability, rural coverage, culturally responsive communication, and continuity of care rather than focusing solely on instrument deployment.

Research Methodology: Evidence-Led Assessment of Diagnostic Practice

This executive summary applies a qualitative, evidence-led framework to adult hemoglobinopathy testing. It considers established diagnostic workflows, clinical use cases, laboratory technologies, health-system conditions, population diversity, regulatory expectations, and regional access factors. Findings are synthesized across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, and across the specified economic and policy groups and countries. The assessment intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Interpretations should be validated against current clinical guidelines, national policies, laboratory standards, and local epidemiology before operational decisions are made.

Conclusion: Better Coordination Will Define the Next Stage of Adult Testing

Adult hemoglobinopathy testing is moving toward more connected, precise, and clinically governed diagnosis. Progress will depend less on individual assays than on the quality of the complete pathway: awareness, specimen handling, analytical performance, interpretation, confirmation, counseling, and follow-up. Regional and country differences make adaptable implementation essential. Leaders that combine laboratory standardization, equitable access, responsible AI, and specialist oversight will be better positioned to improve diagnostic confidence and patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Adult Hemoglobinopathy Testing Market, by Modality
7.1. Introduction
7.2. Laboratory Based Tests
7.2.1. Electrophoresis
7.2.2. Genetic Analysis
7.2.3. High Performance Liquid Chromatography
7.3. Point Of Care Tests
8. Adult Hemoglobinopathy Testing Market, by Disease Type
8.1. Introduction
8.2. Hemoglobin C Disease
8.3. Sickle Cell Disease
8.4. Thalassemia
8.4.1. Alpha Thalassemia
8.4.2. Beta Thalassemia
8.4.3. Delta Thalassemia
9. Adult Hemoglobinopathy Testing Market, by Distribution Channel
9.1. Introduction
9.2. Online
9.3. Offline
10. Adult Hemoglobinopathy Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital Laboratories
10.2.2. Independent Laboratories
10.2.3. Reference Laboratories
10.3. Hospitals
10.3.1. Secondary Care Hospitals
10.3.2. Tertiary Care Hospitals
10.4. Research Institutes
11. Adult Hemoglobinopathy Testing Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. Europe
11.4. North America
11.5. Latin America
11.6. Africa
11.7. Middle East
12. Adult Hemoglobinopathy Testing Market, by Group
12.1. Introduction
12.2. NATO
12.3. G7
12.4. BRICS
12.5. European Union
12.6. ASEAN
12.7. GCC
13. Adult Hemoglobinopathy Testing Market, by Country
13.1. Introduction
13.2. China
13.3. United States
13.4. Japan
13.5. India
13.6. Germany
13.7. United Kingdom
13.8. Australia
13.9. France
13.10. South Korea
13.11. Italy
13.12. Canada
13.13. Russia
13.14. Brazil
13.15. Mexico
13.16. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. ARKRAY, Inc.
15.2. Beckman Coulter, Inc.
15.3. Bio-Rad Laboratories, Inc.
15.4. Bluebird Bio, Inc.
15.5. Creative Diagnostics
15.6. F. Hoffmann-La Roche Ltd.
15.7. HORIBA Group
15.8. Illumina, Inc.
15.9. Laboratory Corporation of America Holdings
15.10. Merck KGaA
15.11. PerkinElmer, Inc.
15.12. Quest Diagnostics Incorporated
15.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
15.14. Shimadzu Corporation
15.15. Siemens Healthineers AG
15.16. Sysmex Europe SE
15.17. Thermo Fisher Scientific Inc.
15.18. Tosoh Corporation
15.19. Trinity Biotech PLC
16. Key Experts
List of Figures
FIGURE 1. Global Adult Hemoglobinopathy Testing Market, Years Considered for the Study
FIGURE 2. Global Adult Hemoglobinopathy Testing Market, Research Design
FIGURE 3. Global Adult Hemoglobinopathy Testing Market, Research Framework
FIGURE 4. Global Adult Hemoglobinopathy Testing Market, Data Triangulation
FIGURE 5. Global Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Adult Hemoglobinopathy Testing Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 7. Global Adult Hemoglobinopathy Testing Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 9. Global Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Adult Hemoglobinopathy Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Adult Hemoglobinopathy Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Adult Hemoglobinopathy Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Adult Hemoglobinopathy Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Adult Hemoglobinopathy Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Adult Hemoglobinopathy Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Adult Hemoglobinopathy Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Adult Hemoglobinopathy Testing Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Adult Hemoglobinopathy Testing Market Segmentation & Coverage
TABLE 2. Global Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 4. Global Laboratory Based Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Laboratory Based Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Laboratory Based Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Electrophoresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Electrophoresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Electrophoresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Genetic Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Genetic Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Genetic Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global High Performance Liquid Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global High Performance Liquid Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global High Performance Liquid Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Point Of Care Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Point Of Care Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Point Of Care Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 20. Global Hemoglobin C Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Hemoglobin C Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Hemoglobin C Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Sickle Cell Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Sickle Cell Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Sickle Cell Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Thalassemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Thalassemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Thalassemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Alpha Thalassemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Alpha Thalassemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Alpha Thalassemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Beta Thalassemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Beta Thalassemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Beta Thalassemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Delta Thalassemia Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Delta Thalassemia Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Delta Thalassemia Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 39. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Hospital Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Hospital Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Hospital Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Independent Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Independent Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Independent Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Secondary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Secondary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Secondary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Tertiary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Tertiary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Tertiary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 80. Europe Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 82. Europe Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 83. Europe Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 84. Europe Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 85. Europe Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Europe Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Europe Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 88. Europe Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 89. North America Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. North America Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 91. North America Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 92. North America Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 93. North America Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 94. North America Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. North America Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. North America Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 97. North America Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 98. Latin America Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Latin America Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 100. Latin America Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 101. Latin America Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 102. Latin America Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 103. Latin America Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 104. Latin America Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Latin America Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 106. Latin America Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 107. Africa Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Africa Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 109. Africa Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 110. Africa Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 111. Africa Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 112. Africa Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. Africa Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Africa Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 115. Africa Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 116. Middle East Adult Hemoglobinopathy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Middle East Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 118. Middle East Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 119. Middle East Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 120. Middle East Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 121. Middle East Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. Middle East Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Middle East Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 124. Middle East Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 125. Global Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. NATO Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. NATO Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 128. NATO Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 129. NATO Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 130. NATO Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 131. NATO Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. NATO Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. NATO Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 134. NATO Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 135. G7 Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. G7 Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 137. G7 Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 138. G7 Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 139. G7 Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 140. G7 Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. G7 Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. G7 Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 143. G7 Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 144. BRICS Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. BRICS Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 146. BRICS Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 147. BRICS Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 148. BRICS Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 149. BRICS Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. BRICS Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. BRICS Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 152. BRICS Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 153. European Union Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. European Union Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 155. European Union Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 156. European Union Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 157. European Union Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 158. European Union Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. European Union Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. European Union Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 161. European Union Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 162. ASEAN Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. ASEAN Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 164. ASEAN Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 165. ASEAN Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 166. ASEAN Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 167. ASEAN Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 168. ASEAN Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. ASEAN Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 170. ASEAN Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 171. GCC Adult Hemoglobinopathy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. GCC Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 173. GCC Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 174. GCC Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 175. GCC Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 176. GCC Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. GCC Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. GCC Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 179. GCC Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. Global Adult Hemoglobinopathy Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. China Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 182. China Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 183. China Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 184. China Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 185. China Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 186. China Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. China Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. China Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 189. China Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 190. United States Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 191. United States Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 192. United States Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 193. United States Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 194. United States Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 195. United States Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. United States Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. United States Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 198. United States Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 199. Japan Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 200. Japan Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 201. Japan Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 202. Japan Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 203. Japan Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 204. Japan Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. Japan Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Japan Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 207. Japan Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 208. India Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 209. India Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 210. India Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 211. India Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 212. India Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 213. India Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. India Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. India Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 216. India Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 217. Germany Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 218. Germany Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 219. Germany Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 220. Germany Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 221. Germany Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 222. Germany Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Germany Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. Germany Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 225. Germany Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. United Kingdom Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 227. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 228. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 229. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 230. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 231. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. United Kingdom Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 234. United Kingdom Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 235. Australia Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 236. Australia Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 237. Australia Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 238. Australia Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 239. Australia Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 240. Australia Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. Australia Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Australia Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 243. Australia Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 244. France Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 245. France Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 246. France Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 247. France Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 248. France Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 249. France Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. France Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. France Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 252. France Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 253. South Korea Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 254. South Korea Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 255. South Korea Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 256. South Korea Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 257. South Korea Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 258. South Korea Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 259. South Korea Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. South Korea Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 261. South Korea Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 262. Italy Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 263. Italy Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 264. Italy Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 265. Italy Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 266. Italy Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 267. Italy Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 268. Italy Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Italy Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 270. Italy Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 271. Canada Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 272. Canada Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 273. Canada Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 274. Canada Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 275. Canada Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 276. Canada Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. Canada Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Canada Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 279. Canada Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 280. Russia Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 281. Russia Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 282. Russia Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 283. Russia Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 284. Russia Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 285. Russia Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. Russia Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Russia Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 288. Russia Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 289. Brazil Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 290. Brazil Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 291. Brazil Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 292. Brazil Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 293. Brazil Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 294. Brazil Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. Brazil Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Brazil Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 297. Brazil Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 298. Mexico Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 299. Mexico Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 300. Mexico Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 301. Mexico Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 302. Mexico Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 303. Mexico Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 304. Mexico Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Mexico Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 306. Mexico Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 307. Spain Adult Hemoglobinopathy Testing Market Size, 2017-2032 (USD Million)
TABLE 308. Spain Adult Hemoglobinopathy Testing Market Size, by Modality, 2017-2032 (USD Million)
TABLE 309. Spain Adult Hemoglobinopathy Testing Market Size, by Laboratory Based Tests, 2017-2032 (USD Million)
TABLE 310. Spain Adult Hemoglobinopathy Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 311. Spain Adult Hemoglobinopathy Testing Market Size, by Thalassemia, 2017-2032 (USD Million)
TABLE 312. Spain Adult Hemoglobinopathy Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 313. Spain Adult Hemoglobinopathy Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. Spain Adult Hemoglobinopathy Testing Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 315. Spain Adult Hemoglobinopathy Testing Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 316. Global Adult Hemoglobinopathy Testing Market Share, by Key Player, 2025
TABLE 317. Global Adult Hemoglobinopathy Testing Market, Key Experts

Companies Mentioned

  • ARKRAY, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bluebird Bio, Inc.
  • Creative Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • HORIBA Group
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Sysmex Europe SE
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Trinity Biotech PLC

Table Information

Report AttributeDetails
No. of Pages185
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.75 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.92 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Adult Hemoglobinopathy Testing - Global Strategic Business Report - Product Image

Adult Hemoglobinopathy Testing - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
HbA1c Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

HbA1c Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 70 Pages
  • Global
From
Beta Thalassemia Testing Market - Global Forecast 2026-2032 - Product Image

Beta Thalassemia Testing Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
D-dimer Testing Market - Global Forecast 2026-2032 - Product Image

D-dimer Testing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Coagulation Testing - Global Strategic Business Report - Product Image

Coagulation Testing - Global Strategic Business Report

  • Report
  • 374 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.